Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
NET patients
.
Show all posts
Showing posts with label
NET patients
.
Show all posts
Friday, February 26, 2016
Chi-Med announces initiation of Phase III sulfatinib registration trial in patients with NETs in China
›
Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison MediPharma Limited ("HMP"...
›
Home
View web version
